DE60302152D1 - Diaminothiazole und ihre anwendung als cdk4 inhibitoren - Google Patents

Diaminothiazole und ihre anwendung als cdk4 inhibitoren

Info

Publication number
DE60302152D1
DE60302152D1 DE60302152T DE60302152T DE60302152D1 DE 60302152 D1 DE60302152 D1 DE 60302152D1 DE 60302152 T DE60302152 T DE 60302152T DE 60302152 T DE60302152 T DE 60302152T DE 60302152 D1 DE60302152 D1 DE 60302152D1
Authority
DE
Germany
Prior art keywords
diaminothiazole
application
cdk4 inhibitors
cdk4
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60302152T
Other languages
English (en)
Other versions
DE60302152T2 (de
Inventor
Xin-Jie Chu
Qingjie Ding
Nan Jiang
Kyungjin Kim
John Lovey
William Mccomas
Guilfoyle Mullin
Wright Tilley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60302152D1 publication Critical patent/DE60302152D1/de
Publication of DE60302152T2 publication Critical patent/DE60302152T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60302152T 2002-05-17 2003-05-12 Diaminothiazole und ihre anwendung als cdk4 inhibitoren Expired - Fee Related DE60302152T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38151302P 2002-05-17 2002-05-17
US381513P 2002-05-17
PCT/EP2003/004939 WO2003097048A1 (en) 2002-05-17 2003-05-12 Diaminothiazoles

Publications (2)

Publication Number Publication Date
DE60302152D1 true DE60302152D1 (de) 2005-12-08
DE60302152T2 DE60302152T2 (de) 2006-07-13

Family

ID=29550137

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302152T Expired - Fee Related DE60302152T2 (de) 2002-05-17 2003-05-12 Diaminothiazole und ihre anwendung als cdk4 inhibitoren

Country Status (16)

Country Link
US (1) US6818663B2 (de)
EP (1) EP1507530B1 (de)
JP (1) JP4308133B2 (de)
KR (1) KR100619515B1 (de)
CN (1) CN100400041C (de)
AR (1) AR040078A1 (de)
AT (1) ATE308323T1 (de)
AU (1) AU2003232754B2 (de)
BR (1) BR0310081A (de)
CA (1) CA2485367A1 (de)
DE (1) DE60302152T2 (de)
ES (1) ES2251697T3 (de)
MX (1) MXPA04011372A (de)
PL (1) PL374581A1 (de)
RU (1) RU2311414C2 (de)
WO (1) WO2003097048A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417196A (pt) * 2003-12-24 2007-03-06 Bayer Cropscience Gmbh regulação de crescimento de planta
US7211576B2 (en) * 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
US7405220B2 (en) 2004-06-09 2008-07-29 Hoffmann-La Roche Inc. Pyrazolopyrimidines
US7705009B2 (en) * 2005-11-22 2010-04-27 Hoffman-La Roche Inc. 4-aminopyrimidine-5-thione derivatives
US9206142B2 (en) 2006-10-31 2015-12-08 Merck Sharp & Dohme Corp. Anilinopiperazine derivatives and methods of use thereof
AR063531A1 (es) 2006-10-31 2009-01-28 Schering Corp Derivados de anilinopiperazina y composicion farmaceutica
EP2313465B1 (de) * 2008-08-12 2015-07-15 Delsper LP Polymerzusammensetzungen mit per(phenylethynyl)arenderivaten
WO2012027481A1 (en) * 2010-08-24 2012-03-01 Gtx, Inc. Compounds for treatment of cancer
JP5918385B2 (ja) 2011-11-18 2016-05-18 デルスパー リミティド パートナーシップ 高ガラス転移点ポリマーのための架橋化合物
ES2782003T3 (es) 2013-04-16 2020-09-09 Memorial Sloan Kettering Cancer Center Compañero de diagnóstico para inhibidores de CDK4
WO2015051525A1 (en) * 2013-10-11 2015-04-16 Rhodia Operations Synthesis of acetal/ketal
WO2017156263A1 (en) 2016-03-09 2017-09-14 Memorial Sloan-Kettering Cancer Center Enigma and cdh18 as companion diagnostics for cdk4 inhibitors
WO2017158147A1 (en) 2016-03-18 2017-09-21 Savira Pharmaceuticals Gmbh Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
WO2018089902A1 (en) * 2016-11-13 2018-05-17 Apogee Biotechnology Corporation Diaminothiazole compounds, compositions and methods of use
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
WO2020222668A1 (en) 2019-04-30 2020-11-05 Instituto de Medicina Molecular João Lobo Antunes Rank pathway inhibitors in combination with cdk inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE332896T1 (de) * 1997-10-27 2006-08-15 Agouron Pharma 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin- abhängiger kinasen
UA71971C2 (en) * 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
MXPA03001189A (es) * 2000-08-09 2004-05-14 Agouron Pharma Compuestos de pirazol-tiazol, composiciones farmaceuticas que los contienen y su uso para inhibir las cinasas dependientes de ciclinas.
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity

Also Published As

Publication number Publication date
KR100619515B1 (ko) 2006-09-08
PL374581A1 (en) 2005-10-31
US6818663B2 (en) 2004-11-16
CN100400041C (zh) 2008-07-09
ATE308323T1 (de) 2005-11-15
ES2251697T3 (es) 2006-05-01
RU2311414C2 (ru) 2007-11-27
CN1652780A (zh) 2005-08-10
JP4308133B2 (ja) 2009-08-05
KR20050006261A (ko) 2005-01-15
AR040078A1 (es) 2005-03-16
AU2003232754A1 (en) 2003-12-02
BR0310081A (pt) 2005-02-15
WO2003097048A1 (en) 2003-11-27
JP2005530783A (ja) 2005-10-13
AU2003232754B2 (en) 2009-03-12
EP1507530A1 (de) 2005-02-23
DE60302152T2 (de) 2006-07-13
CA2485367A1 (en) 2003-11-27
US20040006058A1 (en) 2004-01-08
EP1507530B1 (de) 2005-11-02
MXPA04011372A (es) 2005-08-15
RU2004137110A (ru) 2005-08-20

Similar Documents

Publication Publication Date Title
DE60021423D1 (de) 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE521598T1 (de) 5-phenylthiazol-derivate und ihre verwendung als pi3 kinase inhibitoren
DE602004008303D1 (de) Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
DE60321324D1 (de) Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
DE60315516D1 (de) Pyridazinon-derivate als cdk2-hemmer
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
DE60314600D1 (de) O-cyclopropyl-carboxanilide und ihre verwendung als fungizide
DE60308387D1 (de) Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
DE602005016890D1 (de) Chinolinderivate und ihre verwendung als mycobakterielle inhibitoren
ATE435859T1 (de) Gyraseinhibitoren und deren verwendungen
DE60309874D1 (de) Malonsäuerenitril-verbindungen und ihre verwendung als pestizide
DE60232328D1 (de) Substituierte naphthylindolderivate und ihre verwendung als plasminogen aktivator inhibitor (pai-1) inhibitoren
ATE378049T1 (de) Nicotinamid-derivate als pde4-hemmer
DE60234167D1 (de) Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren
DE50313157D1 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
DE60302152D1 (de) Diaminothiazole und ihre anwendung als cdk4 inhibitoren
ATE357432T1 (de) Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
ATE423117T1 (de) Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone
ATE382040T1 (de) Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren
DE60328978D1 (de) Isochinolinderivate als mao-b inhibitoren
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
ATE483699T1 (de) Neue 2-arylthiazolverbindungen als ppar-alpha und gamma agonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee